Key Record Dates
ClinicalTrials.gov Identifier: | NCT04930783 |
---|---|
Brief Title: | NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma |
First Submitted : | June 11, 2021 |
First Submitted that Met QC Criteria : | June 11, 2021 |
First Posted : | June 18, 2021 |
Last Update Submitted that Met QC Criteria : | March 25, 2024 |
Last Update Posted : | March 27, 2024 |